These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 20399261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Time-oriented experimental design method to optimize hydrophilic matrix formulations with gelation kinetics and drug release profiles.
    Shin S, Choi du H, Truong NK, Kim NA, Chu KR, Jeong SH.
    Int J Pharm; 2011 Apr 04; 407(1-2):53-62. PubMed ID: 21251963
    [Abstract] [Full Text] [Related]

  • 5. A new experimental design method to optimize formulations focusing on a lubricant for hydrophilic matrix tablets.
    Choi du H, Shin S, Khoa Viet Truong N, Jeong SH.
    Drug Dev Ind Pharm; 2012 Sep 04; 38(9):1117-27. PubMed ID: 22348254
    [Abstract] [Full Text] [Related]

  • 6. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug.
    Kikuchi S, Takayama K.
    Int J Pharm; 2010 Feb 15; 386(1-2):149-55. PubMed ID: 19922778
    [Abstract] [Full Text] [Related]

  • 7. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
    Park JS, Shim JY, Park JS, Choi YW, Jeong SH.
    Drug Dev Ind Pharm; 2011 Jun 15; 37(6):664-72. PubMed ID: 21449708
    [Abstract] [Full Text] [Related]

  • 8. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ, Windberg-Baarup A, Neri C, Byway PV, Booth SW, Fitzpatrick S.
    Int J Pharm; 2007 Jun 07; 337(1-2):246-53. PubMed ID: 17306477
    [Abstract] [Full Text] [Related]

  • 9. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T, Alhaique F, Dorigo A, Matricardi P, Grassi M.
    Eur J Pharm Biopharm; 2007 May 07; 66(2):200-9. PubMed ID: 17156985
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH, Tazeen J, Merchant HA, Yousuf RI.
    Pak J Pharm Sci; 2006 Apr 07; 19(2):119-24. PubMed ID: 16751122
    [Abstract] [Full Text] [Related]

  • 11. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study.
    Dahlberg C, Fureby A, Schuleit M, Dvinskikh SV, Furó I.
    J Control Release; 2007 Sep 26; 122(2):199-205. PubMed ID: 17706829
    [Abstract] [Full Text] [Related]

  • 12. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets.
    Li H, Hardy RJ, Gu X.
    AAPS PharmSciTech; 2008 Sep 26; 9(2):437-43. PubMed ID: 18431663
    [Abstract] [Full Text] [Related]

  • 13. Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels.
    Zhang Y, Wu X, Han Y, Mo F, Duan Y, Li S.
    Int J Pharm; 2010 Feb 15; 386(1-2):15-22. PubMed ID: 19895878
    [Abstract] [Full Text] [Related]

  • 14. Monitoring of swelling of hydrophilic polymer matrix tablets by ultrasound techniques.
    Leskinen JT, Hakulinen MA, Kuosmanen M, Ketolainen J, Abrahmsén-Alami S, Lappalainen R.
    Int J Pharm; 2011 Feb 14; 404(1-2):142-7. PubMed ID: 21094229
    [Abstract] [Full Text] [Related]

  • 15. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution.
    Borgquist P, Körner A, Piculell L, Larsson A, Axelsson A.
    J Control Release; 2006 Jul 20; 113(3):216-25. PubMed ID: 16797098
    [Abstract] [Full Text] [Related]

  • 16. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST, Patel LD, Patel DM.
    Acta Pharm; 2008 Jun 20; 58(2):221-9. PubMed ID: 18515232
    [Abstract] [Full Text] [Related]

  • 17. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
    Petrovic A, Cvetkovic N, Ibric S, Trajkovic S, Djuric Z, Popadic D, Popovic R.
    Arch Pharm Res; 2009 Dec 20; 32(12):1767-74. PubMed ID: 20162406
    [Abstract] [Full Text] [Related]

  • 18. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning.
    Xu X, Chen X, Ma P, Wang X, Jing X.
    Eur J Pharm Biopharm; 2008 Sep 20; 70(1):165-70. PubMed ID: 18472256
    [Abstract] [Full Text] [Related]

  • 19. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion.
    Campbell K, Craig DQ, McNally T.
    Int J Pharm; 2008 Nov 03; 363(1-2):126-31. PubMed ID: 18657600
    [Abstract] [Full Text] [Related]

  • 20. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer.
    Ochoa L, Igartua M, Hernández RM, Gascón AR, Pedraz JL.
    J Pharm Pharm Sci; 2005 Jun 29; 8(2):132-40. PubMed ID: 16124924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.